• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MST4:乳腺癌的潜在癌基因和治疗靶点。

MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer.

机构信息

Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.

Markey Cancer Center, Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40508, USA.

出版信息

Cells. 2022 Dec 15;11(24):4057. doi: 10.3390/cells11244057.

DOI:10.3390/cells11244057
PMID:36552828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9777386/
Abstract

The mammalian STE 20-like protein kinase 4 (MST4) gene is highly expressed in several cancer types, but little is known about the role of MST4 in breast cancer, and the function of MST4 during epithelial-mesenchymal transition (EMT) has not been fully elucidated. Here we report that overexpression of MST4 in breast cancer results in enhanced cell growth, migration, and invasion, whereas inhibition of MST4 expression significantly attenuates these properties. Further study shows that MST4 promotes EMT by activating Akt and its downstream signaling molecules such as E-cadherin/N-cadherin, Snail, and Slug. MST4 also activates AKT and its downstream pro-survival pathway. Furthermore, by analyzing breast cancer patient tissue microarray and silicon datasets, we found that MST4 expression is much higher in breast tumor tissue compared to normal tissue, and significantly correlates with cancer stage, lymph node metastasis and a poor overall survival rate ( 0.05). Taken together, our findings demonstrate the oncogenic potential of MST4 in breast cancer, highlighting its role in cancer cell proliferation, migration/invasion, survival, and EMT, suggesting a possibility that MST4 may serve as a novel therapeutic target for breast cancer.

摘要

哺乳动物 STE 20 样蛋白激酶 4(MST4)基因在多种癌症类型中高度表达,但关于 MST4 在乳腺癌中的作用知之甚少,MST4 在上皮-间充质转化(EMT)过程中的功能也尚未完全阐明。在这里,我们报告在乳腺癌中过表达 MST4 会导致细胞生长、迁移和侵袭能力增强,而抑制 MST4 的表达则显著减弱这些特性。进一步的研究表明,MST4 通过激活 Akt 及其下游信号分子,如 E-钙黏蛋白/N-钙黏蛋白、Snail 和 Slug,促进 EMT。MST4 还激活 AKT 及其下游的促生存途径。此外,通过分析乳腺癌患者组织微阵列和硅数据集,我们发现 MST4 在乳腺癌组织中的表达明显高于正常组织,并且与癌症分期、淋巴结转移和总体生存率低显著相关(P<0.05)。总之,我们的研究结果表明 MST4 在乳腺癌中具有致癌潜能,突出了其在癌细胞增殖、迁移/侵袭、存活和 EMT 中的作用,表明 MST4 可能成为乳腺癌的一种新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/f18e9ad2461c/cells-11-04057-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/6f72db4ca302/cells-11-04057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/b429eec94b18/cells-11-04057-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/5647e6069a2d/cells-11-04057-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/ca9da4eb5f98/cells-11-04057-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/6885f0c2a37d/cells-11-04057-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/9d69666beb05/cells-11-04057-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/f18e9ad2461c/cells-11-04057-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/6f72db4ca302/cells-11-04057-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/b429eec94b18/cells-11-04057-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/5647e6069a2d/cells-11-04057-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/ca9da4eb5f98/cells-11-04057-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/6885f0c2a37d/cells-11-04057-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/9d69666beb05/cells-11-04057-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0372/9777386/f18e9ad2461c/cells-11-04057-g007.jpg

相似文献

1
MST4: A Potential Oncogene and Therapeutic Target in Breast Cancer.MST4:乳腺癌的潜在癌基因和治疗靶点。
Cells. 2022 Dec 15;11(24):4057. doi: 10.3390/cells11244057.
2
The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy.哺乳动物无活性丝氨酸/苏氨酸激酶 4(MST4)信号在肿瘤进展中的作用:对治疗的启示。
Cancer Lett. 2023 Jun 1;563:216183. doi: 10.1016/j.canlet.2023.216183. Epub 2023 Apr 22.
3
MST4 promotes hepatocellular carcinoma epithelial-mesenchymal transition and metastasis via activation of the p-ERK pathway.MST4通过激活p-ERK途径促进肝细胞癌上皮-间质转化和转移。
Int J Oncol. 2014 Aug;45(2):629-40. doi: 10.3892/ijo.2014.2455. Epub 2014 May 22.
4
The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.上皮-间充质转化(EMT)调节因子 SLUG(SNAI2)是 SPARC 和 AKT 的下游靶点,可促进黑素瘤细胞侵袭。
PLoS One. 2012;7(7):e40378. doi: 10.1371/journal.pone.0040378. Epub 2012 Jul 20.
5
KRAS gene silencing inhibits the activation of PI3K-Akt-mTOR signaling pathway to regulate breast cancer cell epithelial-mesenchymal transition, proliferation and apoptosis.KRAS 基因沉默抑制 PI3K-Akt-mTOR 信号通路的激活,从而调控乳腺癌细胞上皮-间充质转化、增殖和凋亡。
Eur Rev Med Pharmacol Sci. 2020 Mar;24(6):3085-3096. doi: 10.26355/eurrev_202003_20673.
6
MST4 negatively regulates the EMT, invasion and metastasis of HCC cells by inactivating PI3K/AKT/Snail1 axis.MST4通过使PI3K/AKT/Snail1轴失活来负向调节肝癌细胞的上皮-间质转化、侵袭和转移。
J Cancer. 2021 May 27;12(15):4463-4477. doi: 10.7150/jca.60008. eCollection 2021.
7
SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.SPOCK1/SIX1 轴通过激活 AKT/mTOR 信号通路促进乳腺癌的进展。
Aging (Albany NY). 2020 Dec 3;13(1):1032-1050. doi: 10.18632/aging.202231.
8
WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways.WSTF通过PI3K/Akt和IL-6/STAT3信号通路诱导上皮-间质转化(EMT),从而促进肺癌细胞的增殖和侵袭。
Cell Signal. 2016 Nov;28(11):1673-82. doi: 10.1016/j.cellsig.2016.07.008. Epub 2016 Jul 21.
9
Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.BMI-1 促进侵袭和转移,其高表达与乳腺癌的晚期阶段相关。
Mol Cancer. 2011 Jan 28;10(1):10. doi: 10.1186/1476-4598-10-10.
10
Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.GNAS 表达升高通过 PI3K/AKT/Snail1/E-钙黏蛋白轴促进乳腺癌细胞增殖和迁移。
Clin Transl Oncol. 2019 Sep;21(9):1207-1219. doi: 10.1007/s12094-019-02042-w. Epub 2019 Feb 14.

引用本文的文献

1
Targeting STK26 and ATG4B: miR-22-3p as a modulator of autophagy and tumor progression in HCC.靶向STK26和ATG4B:miR-22-3p作为肝癌自噬和肿瘤进展的调节因子
Transl Oncol. 2025 Jan;51:102214. doi: 10.1016/j.tranon.2024.102214. Epub 2024 Nov 27.
2
Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.遗传敲除 STE20 型激酶 MST4 不能减轻小鼠饮食诱导的 MASLD 易感性。
Int J Mol Sci. 2024 Feb 19;25(4):2446. doi: 10.3390/ijms25042446.
3
Cellular Impacts of Striatins and the STRIPAK Complex and Their Roles in the Development and Metastasis in Clinical Cancers (Review).

本文引用的文献

1
Targeting Akt/PKB in pediatric tumors: A review from preclinical to clinical trials.靶向儿科肿瘤中的 Akt/PKB:从临床前到临床试验的综述。
Pharmacol Res. 2022 Sep;183:106403. doi: 10.1016/j.phrs.2022.106403. Epub 2022 Aug 18.
2
An MST4-pβ-Catenin Signaling Axis Controls Intestinal Stem Cell and Tumorigenesis.MST4-pβ-Catenin 信号轴控制肠道干细胞和肿瘤发生。
Adv Sci (Weinh). 2021 Sep;8(17):e2004850. doi: 10.1002/advs.202004850. Epub 2021 Jul 8.
3
MST4 negatively regulates the EMT, invasion and metastasis of HCC cells by inactivating PI3K/AKT/Snail1 axis.
条纹蛋白和STRIPAK复合体的细胞影响及其在临床癌症发生和转移中的作用(综述)
Cancers (Basel). 2023 Dec 22;16(1):76. doi: 10.3390/cancers16010076.
4
MST4 promotes proliferation, invasion, and metastasis of gastric cancer by enhancing autophagy.MST4通过增强自噬促进胃癌的增殖、侵袭和转移。
Heliyon. 2023 May 29;9(6):e16735. doi: 10.1016/j.heliyon.2023.e16735. eCollection 2023 Jun.
5
The mammalian Sterile 20-like kinase 4 (MST4) signaling in tumor progression: Implications for therapy.哺乳动物无活性丝氨酸/苏氨酸激酶 4(MST4)信号在肿瘤进展中的作用:对治疗的启示。
Cancer Lett. 2023 Jun 1;563:216183. doi: 10.1016/j.canlet.2023.216183. Epub 2023 Apr 22.
MST4通过使PI3K/AKT/Snail1轴失活来负向调节肝癌细胞的上皮-间质转化、侵袭和转移。
J Cancer. 2021 May 27;12(15):4463-4477. doi: 10.7150/jca.60008. eCollection 2021.
4
MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial-Mesenchymal Transition In Gastric Cancer.MST4通过促进胃癌上皮-间质转化预测不良预后并促进转移。
Cancer Manag Res. 2019 Nov 5;11:9353-9369. doi: 10.2147/CMAR.S219689. eCollection 2019.
5
MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma.MST4对ATG4B的磷酸化作用调节胶质母细胞瘤中的自噬活性、致瘤性和放射抗性。
Cancer Cell. 2017 Dec 11;32(6):840-855.e8. doi: 10.1016/j.ccell.2017.11.005.
6
Wnt/β-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling.Wnt/β-连环蛋白信号通路激活微小RNA-150,后者通过抑制CREB信号传导促进结肠癌细胞的上皮-间质转化。
Oncotarget. 2016 Jul 5;7(27):42513-42526. doi: 10.18632/oncotarget.9893.
7
AURKA induces EMT by regulating histone modification through Wnt/β-catenin and PI3K/Akt signaling pathway in gastric cancer.极光激酶A(AURKA)通过Wnt/β-连环蛋白和PI3K/Akt信号通路调节组蛋白修饰,从而在胃癌中诱导上皮-间质转化(EMT)。
Oncotarget. 2016 May 31;7(22):33152-64. doi: 10.18632/oncotarget.8888.
8
Polymorphisms in the AKT1 and AKT2 genes and oesophageal squamous cell carcinoma risk in an Eastern Chinese population.中国东部人群中AKT1和AKT2基因多态性与食管鳞状细胞癌风险
J Cell Mol Med. 2016 Apr;20(4):666-77. doi: 10.1111/jcmm.12750. Epub 2016 Feb 1.
9
Structure-Based Screen Identification of a Mammalian Ste20-like Kinase 4 (MST4) Inhibitor with Therapeutic Potential for Pituitary Tumors.基于结构筛选鉴定具有垂体瘤治疗潜力的哺乳动物类Ste20激酶4(MST4)抑制剂
Mol Cancer Ther. 2016 Mar;15(3):412-20. doi: 10.1158/1535-7163.MCT-15-0703. Epub 2015 Dec 31.
10
Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers.与低分化乳腺癌间充质特征相关的新兴预后标志物。
Tumour Biol. 2016 Apr;37(4):5427-35. doi: 10.1007/s13277-015-4361-7. Epub 2015 Nov 12.